All 2,961 procedure codes billed by Medicaid providers in Georgia, ranked by total spending.
| # | Code | Description | Total Paid |
|---|---|---|---|
| 1 | S5125 | Attendant care services; per 15 minutes | $477.73M |
| 2 | 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | $330.59M |
| 3 | T2033 | Residential care, not otherwise specified (nos), waiver; per diem | $304.11M |
| 4 | 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | $259.38M |
| 5 | T1019 | Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant) | $235.65M |
| 6 | T2025 | Waiver services; not otherwise specified (nos) | $224.62M |
| 7 | 99284 | Emergency department visit for the evaluation and management, high severity | $216.51M |
| 8 | 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | $201.84M |
| 9 | 99283 | Emergency department visit for the evaluation and management, moderate severity | $184.68M |
| 10 | T2017 | Habilitation, residential, waiver; 15 minutes | $165.48M |
| 11 | 90837 | Psychotherapy, 53 minutes with patient | $131.10M |
| 12 | T2022 | Case management, per month | $85.04M |
| 13 | S9351 | Home infusion therapy, continuous or intermittent anti-emetic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and visits coded separately), per diem | $78.79M |
| 14 | T1021 | Home health aide or certified nurse assistant, per visit | $76.98M |
| 15 | T1005 | Respite care services, up to 15 minutes | $60.86M |
| 16 | 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | $54.68M |
| 17 | 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | $42.81M |
| 18 | 90460 | Immunization administration through 18 years of age via any route, first or only component | $42.48M |
| 19 | 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | $40.81M |
| 20 | U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | $38.34M |
| 21 | 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | $37.21M |
| 22 | 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | $35.94M |
| 23 | J1726 | Injection, hydroxyprogesterone caproate, (makena), 10 mg | $32.75M |
| 24 | 97530 | Therapeutic activities, direct patient contact, each 15 minutes | $30.74M |
| 25 | 74177 | Computed tomography, abdomen and pelvis; with contrast material | $29.61M |
| 26 | 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | $29.51M |
| 27 | 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | $29.15M |
| 28 | D1120 | Prophylaxis - child | $25.13M |
| 29 | G0378 | Hospital observation service, per hour | $23.12M |
| 30 | 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | $22.69M |
| 31 | 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | $22.09M |
| 32 | S5102 | Day care services, adult; per diem | $21.98M |
| 33 | G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | $21.97M |
| 34 | D2930 | Prefabricated stainless steel crown - primary tooth | $21.81M |
| 35 | 70551 | Magnetic resonance imaging, brain; without contrast material | $21.71M |
| 36 | T1003 | Lpn/lvn services, up to 15 minutes | $21.69M |
| 37 | 70450 | Computed tomography, head or brain; without contrast material | $21.56M |
| 38 | H2015 | Comprehensive community support services, per 15 minutes | $20.72M |
| 39 | D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | $20.58M |
| 40 | 99282 | Emergency department visit for the evaluation and management, low to moderate severity | $20.49M |
| 41 | 90834 | Psychotherapy, 45 minutes with patient | $20.38M |
| 42 | 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | $20.37M |
| 43 | 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | $19.65M |
| 44 | S9124 | Nursing care, in the home; by licensed practical nurse, per hour | $19.24M |
| 45 | H2017 | Psychosocial rehabilitation services, per 15 minutes | $18.83M |
| 46 | 99233 | Prolong inpt eval add15 m | $18.71M |
| 47 | D0120 | Periodic oral evaluation - established patient | $17.77M |
| 48 | H0031 | Mental health assessment, by non-physician | $17.76M |
| 49 | 99232 | Subsequent hospital care, per day, moderate complexity | $17.31M |
| 50 | A0425 | Ground mileage, per statute mile | $17.20M |
| 51 | A0120 | Non-emergency transportation: mini-bus, mountain area transports, or other transportation systems | $16.95M |
| 52 | S9560 | Home injectable therapy; hormonal therapy (e.g.; leuprolide, goserelin), including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | $16.81M |
| 53 | 95810 | Polysomnography; sleep staging with 4 or more additional parameters | $16.35M |
| 54 | G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | $15.91M |
| 55 | A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | $15.83M |
| 56 | 80053 | Comprehensive metabolic panel | $15.51M |
| 57 | 97153 | Adaptive behavior treatment by protocol, administered by technician, each 15 minutes | $15.26M |
| 58 | 88305 | Level IV - Surgical pathology, gross and microscopic examination | $14.71M |
| 59 | 71046 | Radiologic examination, chest; 2 views | $14.55M |
| 60 | T2028 | Specialized supply, not otherwise specified, waiver | $14.52M |
| 61 | T1015 | Clinic visit/encounter, all-inclusive | $14.27M |
| 62 | H0038 | Self-help/peer services, per 15 minutes | $13.94M |
| 63 | H2019 | Therapeutic behavioral services, per 15 minutes | $13.82M |
| 64 | G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | $13.66M |
| 65 | 96361 | Intravenous infusion, hydration; each additional hour | $13.51M |
| 66 | 95782 | $13.12M | |
| 67 | T1016 | Case management, each 15 minutes | $12.93M |
| 68 | 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | $12.73M |
| 69 | D1351 | Sealant - per tooth | $12.57M |
| 70 | 90999 | Unlisted dialysis procedure, inpatient or outpatient | $12.52M |
| 71 | 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | $12.50M |
| 72 | 76819 | Fetal biophysical profile; without non-stress testing | $12.29M |
| 73 | H0039 | Assertive community treatment, face-to-face, per 15 minutes | $12.18M |
| 74 | 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | $11.74M |
| 75 | D2391 | Resin-based composite - one surface, posterior, primary or permanent | $11.72M |
| 76 | 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | $11.48M |
| 77 | 90853 | Group psychotherapy (other than of a multiple-family group) | $11.45M |
| 78 | 99215 | Prolong outpt/office vis | $11.16M |
| 79 | 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | $10.95M |
| 80 | 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | $10.95M |
| 81 | 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | $10.65M |
| 82 | D0274 | Bitewings - four radiographic images | $10.61M |
| 83 | 93325 | $10.46M | |
| 84 | D1208 | Topical application of fluoride, excluding varnish | $10.37M |
| 85 | 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | $10.34M |
| 86 | 44970 | $10.11M | |
| 87 | J1599 | Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg | $9.95M |
| 88 | D0150 | Comprehensive oral evaluation - new or established patient | $9.82M |
| 89 | A0160 | Non-emergency transportation: per mile - case worker or social worker | $9.78M |
| 90 | 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | $9.66M |
| 91 | 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | $9.44M |
| 92 | D0272 | Bitewings - two radiographic images | $9.40M |
| 93 | 90792 | Psychiatric diagnostic evaluation with medical services | $9.35M |
| 94 | A0090 | Non-emergency transportation, per mile - vehicle provided by individual (family member, self, neighbor) with vested interest | $9.30M |
| 95 | 99601 | $9.30M | |
| 96 | D7240 | Removal of impacted tooth - completely bony | $9.21M |
| 97 | 71045 | Radiologic examination, chest; single view | $9.17M |
| 98 | 0202U | Oncology (prostate), multianalyte, gene expression profiling | $9.07M |
| 99 | 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | $8.97M |
| 100 | S5130 | Homemaker service, nos; per 15 minutes | $8.95M |
| 101 | 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | $8.89M |
| 102 | A4353 | Intermittent urinary catheter, with insertion supplies | $8.83M |
| 103 | G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | $8.80M |
| 104 | 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | $8.62M |
| 105 | 80061 | Lipid panel | $8.61M |
| 106 | D1110 | Prophylaxis - adult | $8.61M |
| 107 | 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | $8.55M |
| 108 | 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | $8.54M |
| 109 | 99223 | Prolong inpt eval add15 m | $8.50M |
| 110 | 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | $8.29M |
| 111 | 90832 | Psychotherapy, 30 minutes with patient | $8.26M |
| 112 | 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | $8.16M |
| 113 | A9274 | External ambulatory insulin delivery system, disposable, each, includes all supplies and accessories | $8.11M |
| 114 | 74176 | Computed tomography, abdomen and pelvis; without contrast material | $8.03M |
| 115 | 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | $7.99M |
| 116 | 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | $7.96M |
| 117 | 84443 | Thyroid stimulating hormone (TSH) | $7.72M |
| 118 | J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | $7.55M |
| 119 | 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | $7.53M |
| 120 | 97150 | Therapeutic procedure(s), group (2 or more individuals) | $7.52M |
| 121 | A0100 | Non-emergency transportation; taxi | $7.52M |
| 122 | 90847 | Family psychotherapy with the patient present, 50 minutes | $7.50M |
| 123 | D9420 | $7.48M | |
| 124 | 80050 | General health panel | $7.42M |
| 125 | 99244 | Office or other outpatient consultation, moderate to high complexity | $7.32M |
| 126 | D0220 | Intraoral - periapical first radiographic image | $7.23M |
| 127 | 76770 | $7.11M | |
| 128 | 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | $7.07M |
| 129 | 96375 | Therapeutic injection; each additional sequential IV push | $7.06M |
| 130 | 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | $7.03M |
| 131 | 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | $7.00M |
| 132 | U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | $6.71M |
| 133 | H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | $6.66M |
| 134 | S9211 | Home management of gestational hypertension, includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately); per diem (do not use this code with any home infusion per diem code) | $6.65M |
| 135 | A9276 | Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply | $6.50M |
| 136 | 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | $6.49M |
| 137 | 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | $6.38M |
| 138 | H0032 | Mental health service plan development by non-physician | $6.30M |
| 139 | 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | $6.23M |
| 140 | D7140 | Extraction, erupted tooth or exposed root | $6.16M |
| 141 | 99051 | $6.07M | |
| 142 | J1745 | Injection, infliximab, excludes biosimilar, 10 mg | $6.07M |
| 143 | V2020 | Frames, purchases | $5.90M |
| 144 | 70543 | $5.88M | |
| 145 | D1206 | Topical application of fluoride varnish | $5.88M |
| 146 | D0330 | Panoramic radiographic image | $5.81M |
| 147 | S5170 | Home delivered meals, including preparation; per meal | $5.73M |
| 148 | T2048 | Behavioral health; long-term care residential (non-acute care in a residential treatment program where stay is typically longer than 30 days), with room and board, per diem | $5.51M |
| 149 | P9016 | Red blood cells, leukocytes reduced, each unit | $5.51M |
| 150 | 95812 | $5.39M | |
| 151 | D0230 | Intraoral - periapical each additional radiographic image | $5.31M |
| 152 | 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | $5.26M |
| 153 | 74230 | $5.17M | |
| 154 | 88312 | $5.10M | |
| 155 | 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | $5.07M |
| 156 | 74183 | $5.06M | |
| 157 | T1020 | Personal care services, per diem, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant) | $5.04M |
| 158 | 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | $5.04M |
| 159 | 81408 | $5.04M | |
| 160 | U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | $5.02M |
| 161 | S9123 | Nursing care, in the home; by registered nurse, per hour (use for general nursing care only, not to be used when cpt codes 99500-99602 can be used) | $4.96M |
| 162 | 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | $4.94M |
| 163 | J3490 | Unclassified drugs | $4.90M |
| 164 | T1002 | Rn services, up to 15 minutes | $4.88M |
| 165 | 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | $4.87M |
| 166 | 90791 | Psychiatric diagnostic evaluation | $4.84M |
| 167 | 99479 | Subsequent intensive care, per day, very low birth weight infant | $4.79M |
| 168 | 72197 | $4.74M | |
| 169 | D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | $4.73M |
| 170 | 76705 | Ultrasound, abdominal, real time with image documentation; limited | $4.66M |
| 171 | 83036 | Hemoglobin; glycosylated (A1C) | $4.66M |
| 172 | H2014 | Skills training and development, per 15 minutes | $4.66M |
| 173 | 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | $4.63M |
| 174 | 99309 | Subsequent nursing facility care, per day, low to moderate complexity | $4.60M |
| 175 | 87428 | $4.58M | |
| 176 | 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | $4.48M |
| 177 | 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | $4.46M |
| 178 | 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | $4.45M |
| 179 | 71260 | Computed tomography, thorax, diagnostic; with contrast material | $4.43M |
| 180 | 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | $4.40M |
| 181 | V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | $4.35M |
| 182 | 93975 | $4.34M | |
| 183 | H2012 | Behavioral health day treatment, per hour | $4.30M |
| 184 | 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | $4.29M |
| 185 | 92611 | $4.24M | |
| 186 | 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | $4.24M |
| 187 | H0044 | Supported housing, per month | $4.22M |
| 188 | 76825 | $4.18M | |
| 189 | 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | $4.09M |
| 190 | 76818 | $4.08M | |
| 191 | S9214 | Home management of gestational diabetes, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately); per diem (do not use this code with any home infusion per diem code) | $4.05M |
| 192 | 87799 | $4.05M | |
| 193 | T1001 | Nursing assessment / evaluation | $4.02M |
| 194 | H0004 | Behavioral health counseling and therapy, per 15 minutes | $4.00M |
| 195 | 87086 | Culture, bacterial; quantitative colony count, urine | $3.97M |
| 196 | 99472 | Subsequent inpatient pediatric critical care, per day, 2-5 years | $3.93M |
| 197 | J1729 | Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg | $3.92M |
| 198 | 76700 | Ultrasound, abdominal, real time with image documentation; complete | $3.91M |
| 199 | 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | $3.84M |
| 200 | D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | $3.84M |